As previously reported, there is an increased number of PECs within the glomerular tuft that expresses the activation marker CD44 in the early stages of FSGS, whereas few activated PECs are observed in MCD (Fatima et al., 2012). The gene discussed is CD44; the disease is focal segmental glomerulosclerosis.